The effect of the intravenous administration of procaine amide in 25 patients with supraventricular arrhythmias is reported. The data, including six conversions of auricular fibrillation, indicate a pronounced effect of this drug on the auricles as well as on the heart as a whole. Special attention is directed to the finding of frequent and undesirable electrocardiographic and hypotensive effects of this drug. P ROCAINE amide hydrochloride has been reported to be of value in the management of cardiac arrhythmias of ventricular origin.' It has been considered as having little effect on the auricles. The present report describes the results of the intravenous administration of procaine amide in 25 patients with cardiac arrhythmias of supraventricular origin.
-MATERIAL AND METHODS The effect of I)rocaine amide on 25 patients with sup)raventricular arrhythmias was studied. There were 16 patients with auricular fibrillation, 4 with auricular flutter, 3 with paroxy-smal supraventricular tachycardia, and 2 with frequent premature auricular contractions.
All of the cases were men in the older age group with an age range of 45 to 77 years. The majority had arteriosclerotic heart disease, hypertensive heart disease, or both. Three patients had rheumatic valvular heart disease; 2, aortic insufficiency due to syphilitic aortitis; and one each, pericarditis, cor pulmonale, and thyrotoxicosis. In 2 cases there was no evidence of heart disease.
The drug, which comes in 10 cc. vials, was diluted to 30 cc. with normal saline and administered intra- venously in all cases. The dose of procaine amide given intravenously ranged from 300 mg. to 2000 published with the approval of the Chief Medica31 Director. The auricular fibrillation recently, with the onset of fibrillation occurring a fewshours to a maximum of two months prior to treatment. The 5 patients satisfactorily converted to and maintained in normal sinus rhythm fell into this group. The remaining 2 patients were subsequently treated with quinidine and one patient converted to normal sinus rhythm. Of the 16 patients 9 could be classified as having chronic auricular fibrillation of several years duration. Further attempts at conversion with other drugs were not undertaken in this group. Premature Auricular Systoles There were 2 patients (cases 24, 25) with frequent auricular premature systoles who were treated with intravenous procaine amide. The premature contractions were eliminated in one patient and decreased in frequency in another.
ELECTROCARDIOGRAPHIC CHANGES P-it intervals were measurable in 11 patients after conversion of the arrhythmia. In only 2 patients was the P-R interval significantly prolonged, with P-R interval measurements of 0.22 second in each instance. However, in one of these first degree A-V block was present before treatment.
In 24 of 25 cases widening of the QRS interval could be demonstrated. This was usually also maximal at the end of injection. All QRS intervals were within normal limits of 0.10 second or less in the control leads. There were 5 patients who showed widening of the QRS interval of from 0.12 to 0.14 second. However, only 2 patients could be considered to have shown a 50 per cent increase in QRS time.
QRS changes consisted chiefly of widening and slurring except in case 7 in which right bundle branch block developed and in case 21 in which left bundle branch block developed.
Q-T intervals were usually more difficult to estimate with accuracy because of the underlying arrhythmia and distortion of the baseline. In 13 patients in which measurements were feasible, some prolongation of the Q-T interval was noted in every instance. By the use of the Ashman-Hull tables for determining normal Q-T intervals, all but one patient could be considered to have abnormal Q-T intervals during or immediately following administration of the drug. Only one patient had an abnormal Q-T interval prior to therapy.
S-T segment and T wave changes were on the whole not remarkable except in the 2 patients who developed bundle branch block. There were 6 patients who showed an increase in voltage of the T wave in lead II. Others showed slight flattening of T waves associated with prolongation of the Q-T interval.
The most serious electrocardiographic changes noted were short bursts of paroxysmal ventricular tachycardia. This arrhythmia occurred in 2 patients (cases 6a, b, 14). In case 6a, 1000 mg. or 10.3 mg. per Kg. was administered intravenously at a rate of 100 mg. per minute. Immediately after the injection short bursts of paroxysmal ventricular tachycardia were noted ( fig. 4) . These continued for 20 minutes with decreasing frequency. Occasional premature ventricular contractions could still be detected 30 minutes later. These findings were reproduced the following day when the same amount of procaine amide was again administered intravenously but at half the previous rate (case 6b). Similar findings were noted in case 14 in which 31.9 mg. per Kg. of body weight was given. Administration was discontinued when a sudden paroxysm of ventricular tachycardia developed. The tachycardia stopped spontaneously in 10 seconds and recurred several times in the next three minutes. In the following 30 minutes only an occasional premature ventricular contraction was seen. As in the previous patient the development of an occasional ventricular premature contraction heralded the onset of ventricular tachycardia and should probably constitute an indication for prompt cessation of administration. It is worth noting that in the latter patient the toxic dose was three times as great in terms of mg. per Kg. of body weight. No subjective symptoms were observed in either patient.
-GENERAL CLINICAL FINDINGS AND DOSAGE Blood pressure recordings were made at two minute intervals on 16 patients. Of the 16 patients, 12 showed a slight to moderate drop in systolic pressures and to a lesser degree in diastolic pressures. Four patients (cases 1, 3, 14, 25) could be considered to have a significant fall in blood pressure with at least a 50 mm. lowering of systolic pressure. The changes in blood pressure were noted fairly early during administration of procaine amide. the effect of this drug on the heart was demonstrated in nearly all patients by mild to marked degrees of QRS and Q-T interval prolongation.
5. An increase in ventricular rate in auricular fibrillation and a decrease in auricular-ventricular ratio in auricular flutter was a constant finding.
6. "Toxic" or undesirable changes were observed in 8 patients. Two patients with short paroxysms of ventricular tachycardia deserve special emphasis. 7 . Considerable variation in individual sensitivity to procaine amide and the frequent unfavorable manifestations seen make necessary careful electrocardiographic and blood pressure control during intravenous administration of this drug.
